ACB(ACB)
ACB
ANALYST COVERAGE14 analysts
HOLD
▲ +124.7%upside to target
L $1.00
Med $8.00consensus
H $8.75PRICE
Prev Close
3.47
Open
3.44
Day Range3.41 – 3.58
3.41
3.58
52W Range3.07 – 6.67
3.07
6.67
14% of range
VOLUME & SIZE
Avg Volume
928.0K
FUNDAMENTALS
P/E Ratio
-3.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.86
High vol
TECHNICAL
RSI (14)
43
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 159 days
Oct 27
ACB News
About
aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Michael Singer
Country
Canada
Website
Alex MillerExecutive Vice President of Operations & Supply Chain
Andre JeromeExecutive Vice President of Global Business Development
Michelle LeflerVice President of Communications & Public Relations
David AirdExecutive Vice President of Information Technology
Miguel MartinChief Executive Officer & Executive Chairman
Rick SavoneSenior Vice President of Global Government Relations
Lori SchickExecutive Vice President of Human Resources
Nathalie ClarkExecutive Vice President, General Counsel & Corporate Secretary
Simona KingChief Financial Officer
Kerry MillerManaging Director for Australia & New Zealand